Alembic gets nod to demerge Real Estate undertaking into Shreno

12 Sep 2018 Evaluate

Alembic has received approval to demerge the identified real estate undertaking of the company into Shreno, an unlisted public limited company, to be implemented by way of a Scheme of Arrangement. The identified real estate undertaking proposed to be demerged would comprise of the Project Management Consultancy (PMC) business, services of which are provided by the company to Shreno. The Board of Directors of the company at its meeting held on September 11, 2018, approved the same.

Alembic is engaged in manufacturing of active pharmaceutical ingredients for anti-parkinsons, anti-depressants, cephalosporins, macrolides and others.

Alembic Share Price

101.06 1.20 (1.20%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Lodha Developers 1061.30
Dilip Buildcon 476.25
DLF 687.65
Oberoi Realty 1670.85
Ahluwalia Contract(I 980.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×